CClinicalTrials.gg
CompletedNCT01714349Updated Jul 6, 2026

Nerve Transfer After Spinal Cord Injuries

An interventional study of Nerve Transfer in Spinal Cord Injury, sponsored by Washington University School of Medicine. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-07-06.

Sponsored by Washington University School of Medicine · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Nerve Transfer surgery can provide improved hand function following cervical spinal cord injuries

Read the detailed description

Current treatment strategies of acute cervical spinal cord injuries remain limited. Treatment options that provide meaningful improvements in patient quality of life and long-term functional independence will provide a significant public health impact.

Specific Aim: Measure the efficacy of nerve transfer surgery in the treatment of patients with complete cervical spinal cord injuries with no hand function. Optimize the efficiency of nerve transfer surgery by evaluating patient outcomes in relation to patient selection and optimal timing the the surgery.

Hypothesis: Peripheral nerve transfers in patients with spinal cord injuries will improve hand function and provide improvement in patient quality of life and functional independence.

02

Conditions studied

  • Spinal Cord Injury

Keywords

  • Spinal cord injury
  • nerve transfer
  • tetraplegia
  • quadriplegia
03

In context

Spinal Cord Injuries

1,948 studies on the registry are indexed under Spinal Cord Injuries; 505 are open to participants now.

This study's enrollment of 20 is below the median of 24 across 1,566 interventional studies indexed under Spinal Cord Injuries.

Browse Spinal Cord Injuries studies →

Lead sponsor

Washington University School of Medicine is the lead sponsor of 1,765 studies on the registry; 271 are open to participants now.

Of its 324 completed or terminated interventional studies of FDA-regulated products, 212 (65%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. 18-65 years of age
  2. Informed Consent Document (ICD) signed by patient
  3. Cervical spinal cord injury resulting in arm \& hand functional impairment, with at least preserved elbow function
  4. International Classification of Surgery of the Hand in Tetraplegia (ICSHT) category 0 - 4
  5. Patients with a stable American Spinal Injury Association (ASIA) grade of A, B, or C, or with a diagnosis of central cord syndrome, showing minimal to no evidence of functional improvement in motor examination after at least 6 months of non-operative therapy post-injury
  6. Appropriate candidate for nerve transfer study
  7. Willing and able to comply with the study protocol
  8. \< 48 months from injury

Exclusion criteria

Exclusion Criteria:

  1. Active infection at the operative site or systemic infection
  2. Any return or ongoing clinical recovery of distal motor function within 6 months after injury
  3. Physically or mentally compromised
  4. Currently undergoing long-term steroid therapy
  5. Significant joint contractures and/or limitations in passive range of motion in the arm or hand
  6. Active malignancy
  7. Systemic disease that would affect the patient's welfare or the research study
  8. Pregnant
  9. Immunologically suppressed or immunocompromised
  10. Significant pain or hypersensitivity
  11. Previous or current injury preventing use of tendon transfers to restore upper extremity function
  12. Affective disorder of a degree that would make outcome assessment and study participation difficult
  13. History of brachial plexus injury or systemic neuropathic process
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (actual)

Study arms

  • Experimental
    Nerve Transfer

    Surgical - Nerve transfers for patients with stable cervical spinal cord injuries

    Procedure: Nerve Transfer

Interventions

  • ProcedureNerve Transfer

    A nerve transfer procedure will be individualized to each patient's functional deficit.

06

What researchers measure

Primary outcomes

  1. Change in upper motor strength

    Patients motor strength will be assessed over 48 months of clinical follow-up with conventional manual motor testing

    Time frame: 48 months

Secondary outcomes

  1. Change in Disabilities of Arm, Shoulder, and Hand (DASH) scores

    The change in DASH scores will be followed over time and assessed pre-operatively, 6,12, 18, 24, 36 and 48 months post-operatively.

    Time frame: 48 months

  2. Change in Short Form 36 (SF-36) scores

    The change in SF-36 scores will be followed over time and assessed pre-operatively, 6, 12, 18, 24. 36 and 48 months post-operatively.

    Time frame: 48 months

  3. Change in Michigan Hand Questionnaire (MHQ)

    The change in MHQ will be followed over time and assessed pre-operatively, 6, 12, 18, 24, 36 and 48 months post-operatively.

    Time frame: 48 months

Other outcomes

  1. Rates of Intraoperative and Post-operative complications

    The number of complications within and after the operation.

    Time frame: 48 months

  2. Effect of timing on surgical intervention

    Assess the effect of timing on primary and secondary outcome measures, early (\<12 months) vs. (\>12 months)

    Time frame: 48 months

  3. Rate of reoperation

    The rate at which a patient needs to be operated on again.

    Time frame: 48 months

  4. Hand Function, measured by the Sollerman Hand Function Test

    The Sollerman Hand Function Test is performed as part of an overall evaluation and assessment by study team Occupational Therapist pre-operatively, post-operatively, and at 6 months, 12 months, 18 months, and 24 months. 36 months and 48 months

    Time frame: 48 months

07

Study locations

1 site
  • Washington University
    St Louis, Missouri 63110, United States
08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01714349
Lead sponsor
Washington University School of Medicine
Collaborators
United States Department of Defense, Congressionally Directed Medical Research Programs
Responsible party
Sponsor
First posted
Oct 25, 2012
Start date
Oct 2012
Primary completion
Mar 20, 2023
Completion
Mar 20, 2023
Last update
Jul 6, 2026

Study contacts

Wilson Z Ray, MD
principal investigator · Washington University School of Medicine

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion